PRSMEDIUM SIGNALFINANCIAL10-K

PRS delivered strong 31% net income growth to $3.6B despite revenue decline and reduced operating cash flows, while expanding its reinsurance partnership with Prismic.

The divergence between declining revenue (-13.7%) and rising net income (+31%) suggests improved operational efficiency or favorable one-time items that warrant closer examination. The company has reduced its outstanding share count from 354M to 348M shares, indicating continued capital returns to shareholders through buybacks.

Comparing 2026-02-12 vs 2025-02-13View on EDGAR →
FINANCIAL ANALYSIS

PRS shows mixed financial performance with net income surging 31% to $3.6B while revenue fell 13.7% to $60.8B, suggesting either significant margin expansion or non-recurring gains. Operating cash flow declined 26% to $6.3B, creating a concerning disconnect with the strong earnings growth and indicating potential working capital pressures or timing differences. Stockholders' equity grew a healthy 16.4% to $32.4B, reflecting retained earnings growth and supporting the company's capital position despite the operational cash flow decline.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+31.1%
$2.7B$3.6B

Net income grew 31.1% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-26.2%
$8.5B$6.3B

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Stockholders Equity
Balance Sheet
+16.4%
$27.9B$32.4B

Equity base grew 16.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Revenue
P&L
-13.7%
$70.4B$60.8B

Revenue softened 13.7% — monitor whether this is cyclical or structural.

LANGUAGE CHANGES
NEW — 2026-02-12
PRIOR — 2025-02-13
ADDED
As of January 31, 2026, 348 million shares of the registrant s Common Stock (par value $0.01) were outstanding.
In September 2023, we, together with Warburg Pincus and a group of institutional investors, launched Prismic Life Reinsurance, Ltd.
Through our Corporate and Other operations, we own an approximate 20% equity interest in Prismic Life Holding Company LP ( Prismic ), the Bermuda-exempted limited partnership that owns all of the outstanding capital stock of Prismic Re and Prismic Life Reinsurance International, Ltd.
See Note 15 to the Consolidated Financial Statements for additional information regarding our transactions with Prismic Re and Prismic Re International.
Our strategy centers on capturing powerful tailwinds, including those at the convergence of global retirement and asset management, to be a global leader in expanding access to investing, insurance, and retirement security.
Investment Asset Classes Public Fixed Income Global active asset management capabilities across public fixed income markets that offer liquidity and risk management for investors.
Private Credit and Other Alternatives Alternatives and private credit solutions across the risk spectrum, including investment grade, high yield, direct lending, mezzanine financing, and secondary transactions in the small and mid-cap markets.
Public Equity Active fundamental public equity asset management capabilities across an array of growth, value, global and specialty equity strategies.
Real Estate A broad range of public and private real estate debt and equity strategies as well as private equity investments.
Multi-Asset Primarily public and private multi-asset class liability-driven investment solutions to institutional clients, including funds or products that invest in more than one asset class, balancing equity and fixed income funds, and target date funds.
REMOVED
As of January 31, 2025, 354 million shares of the registrant s Common Stock (par value $0.01) were outstanding.
and (f) privacy and cybersecurity regulation; (8) technological changes which may adversely impact companies in our investment portfolio or cause insurance experience to deviate from our assumptions; (9) an inability to protect our intellectual property rights or claims of infringement of the intellectual property rights of others; (10) ratings downgrades; (11) market conditions that may adversely affect the sales or persistency of our products; (12) competition; (13) reputational damage; and (14) the costs, effects, timing, or success of our plans to execute our strategy.
In September 2023, we, together with Warburg Pincus and a group of institutional investors, announced the launch of Prismic Life Reinsurance, Ltd.
In conjunction with this announcement, we made an initial equity investment through our Corporate and Other operations of approximately $200 million, equivalent to a 20% interest, in Prismic Life Holding Company LP ( Prismic ), the Bermuda-exempted limited partnership that owns all of the outstanding capital stock of Prismic Re.
As this investment is accounted for under the equity method, both Prismic and Prismic Re are considered related parties.
For additional information regarding related party transactions, see Note 24 to the Consolidated Financial Statements.
Our strategy centers on leveraging our mutually-reinforcing business system to become a higher growth, less market-sensitive and more nimble company.
Products Our products and services are offered through the following businesses: PGIM Fixed Income provides global active asset management services across public fixed income markets, as well as alternatives.
Jennison Associates provides active fundamental public equity and fixed income asset management services across an array of growth, value, global and specialty equity strategies, as well as fixed income strategies.
PGIM Quantitative Solutions provides a range of systematic, customized solutions across equity, multi-asset, and liquid alternative platforms.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →